References
- Spera RV Jr, Farber BF. Multidrug-resistant Enterococcus faecium: an untreatable nosocomial pathogen. Drugs 1994; 48(5): 678–88
- Centers for Disease Control and Prevention. Nosocomial Enterococci resistant to vancomycin— United States, 1989–1993. MMWR 1993; 42(30): 597–9
- Spera RV Jr, Farber BF. Multiply-resistant Enterococcus faecium: the nosocomial pathogen of the 1990s. JAMA 1992; 268(18): 2563–4
- Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3(1): 46–65
- Chenoweth C, Schaberg D. The epidemiology of Enterococci. Eur J Clin Microbiol Infect Dis 1990; 9(2): 80–9
- Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91(Suppl 3B): 72–5S
- Patterson JE, Zervos MJ. High-level gen-tamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology. Rev Infect Dis 1990; 12(4): 644–52
- Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993; 342(8863): 76–9
- Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993; 16(6): 750–5
- Morris JG Jr, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 1995; 123(4): 250–9
- Livornese LL Jr, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin- resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992; 117(2): 112–6
- Lam S, Singer C, Tucci V, et al. The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study. Am J Infect Control 1995; 23(3): 170–80
- Noskin GA, Stosor V, Cooper I, et al. Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces. Infect Control Hosp Epidemiol 1995; 16(10): 577–81
- Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994; 32(5): 1148–53
- Nicas TI, Mullen DL, Flokowitsch JE, et al. Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria. J Antimicrob Chemother 1995: 39(11): 2585–7
- Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1995; 44(RR-12): 1–13
- Boyce JM, Mermel LA, Zervos MJ, et al. Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1995; 16: 634–7